{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:49:45Z","timestamp":1791578985754,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Characterize physician anticoagulation practices after stent placement in patients with venous occlusive disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Survey-based analysis was conducted between January 2023 and April 2023 (for 109\u00a0days) evaluating practices of post venous stent placement anticoagulation regimens. A survey investigated provider demographics, agent selection, dosing, duration, and patient factors taken in agent choice. The survey was distributed through email lists and promoted on social media and limited users to one response. Questions stratified for both superior vena cava (SVC) and upper extremity and inferior vena cava (IVC) and lower extremity interventions. Descriptive statistics determined the significance of the regimen utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred twenty-nine respondents participated in the study, with interventional radiologists constituting 94%. The preferred regimen for SVC interventions was direct oral anticoagulants (DOAC) and single antiplatelet therapy, accounting for 39\/117 of respondents. For IVC interventions, low molecular weight heparin (LMWH) and single antiplatelet therapy was the regimen of choice representing 12\/38 of preferences. SVC intervention therapy duration was most common to be lifetime for aspirin (10; 43%), 3\u00a0months for non-ASA antiplatelet agents (23; 52%), and 6\u00a0months for anticoagulants (32; 44%). For IVC therapies, the trend of drug duration for aspirin was most common to be lifetime (6;40%), for non-ASA antiplatelets was 3\u00a0months (10; 53%), and for anticoagulants tied for 6 and 12\u00a0months (7; 30% each). Eight risk factors affected post-intervention anticoagulation selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This work highlights the most common post-venous stenting anticoagulation regimens currently in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42155-026-00763-y","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:26:14Z","timestamp":1791530774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation practices in venous occlusive disease after stent placement"],"prefix":"10.1186","volume":"9","author":[{"given":"Omar","family":"Ayman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4913-5945","authenticated-orcid":false,"suffix":"IV","given":"Warren A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeonjeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F. B.","family":"Chick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina S.","family":"Makary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"763_CR1","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1055\/s-0039-1697955","volume":"119","author":"T Sebastian","year":"2019","unstructured":"Sebastian T, Spirk D, Engelberger RP, Dopheide JF, Baumann FA, Barco S, et al. Incidence of stent thrombosis after endovascular treatment of iliofemoral or caval veins in patients with the postthrombotic syndrome. Thromb Haemost. 2019;119:2064\u201373. https:\/\/doi.org\/10.1055\/s-0039-1697955.","journal-title":"Thromb Haemost"},{"key":"763_CR2","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jvir.2021.08.002","volume":"32","author":"E Von Ende","year":"2021","unstructured":"Von Ende E, Gayou EL, Chick JFB, Makary MS. Nationwide trends in catheter-directed therapy utilization for the treatment of lower extremity deep vein thrombosis in Medicare beneficiaries. J Vasc Interv Radiol. 2021;32:1576-1582.e1. https:\/\/doi.org\/10.1016\/j.jvir.2021.08.002.","journal-title":"J Vasc Interv Radiol"},{"key":"763_CR3","unstructured":"Society of interventional radiology position statement on the management of chronic iliofemoral venous obstruction with endovascular placement of metallic stents-ClinicalKey. n.d. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S1051044323004268?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1051044323004268%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F. Accessed 15 May 2025."},{"key":"763_CR4","unstructured":"Optimal medical therapy following deep venous interventions: proceedings from the society of interventional radiology foundation research consensus panel-ClinicalKey. n.d. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S1051044321013798?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1051044321013798%3Fshowall%3Dtrue&referrer=. Accessed 15 May 2025."},{"key":"763_CR5","unstructured":"Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease-ClinicalKey. n.d. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S2213333X17305061?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2213333X17305061%3Fshowall%3Dtrue&referrer=. Accessed 15 May 2025."},{"key":"763_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiology.200.1.8657909","volume":"200","author":"GK Nazarian","year":"1996","unstructured":"Nazarian GK, Bjarnason H, Dietz CA, Bernadas CA, Hunter DW. Iliofemoral venous stenoses: effectiveness of treatment with metallic endovascular stents. Radiology. 1996;200:193\u20139. https:\/\/doi.org\/10.1148\/radiology.200.1.8657909.","journal-title":"Radiology"},{"key":"763_CR7","unstructured":"Editor\u2019s Choice\u2013a systematic review of endovenous stenting in chronic venous disease secondary to iliac vein obstruction-ClinicalKey. n.d. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S1078588415006772?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1078588415006772%3Fshowall%3Dtrue&referrer=. Accessed 15 May 2025."},{"key":"763_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2214\/AJR.22.27413","volume":"219","author":"S Kishore","year":"2022","unstructured":"Kishore S, Khaja MS, Thornburg B, Sharma AM, Knuttinen M-G, Shamoun F, et al. Antithrombotic therapy after venous interventions: AJR expert panel narrative review. Am J Roentgenol. 2022;219:175\u201387. https:\/\/doi.org\/10.2214\/AJR.22.27413.","journal-title":"Am J Roentgenol"},{"key":"763_CR9","unstructured":"Antithrombotic therapy following venous stenting: international Delphi consensus-ClinicalKey. n.d. \nhttps:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S1078588418300364?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1078588418300364%3Fshowall%3Dtrue&referrer=https:%2F%2Fverjournal.com%2F. Accessed 15 May 2025."},{"key":"763_CR10","unstructured":"Antithrombotic therapy after venous stent placement\u2013vascular and endovascular review. 2020. \nhttps:\/\/verjournal.com\/antithrombotic-therapy-after-venous-stent-placement\/.\u00a0Accessed 15 May 2025."},{"key":"763_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ejvs.2018.01.007","volume":"55","author":"K Milinis","year":"2018","unstructured":"Milinis K, Thapar A, Shalhoub J, Davies AH. Antithrombotic therapy following venous stenting: international Delphi consensus. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2018;55:537\u201344. https:\/\/doi.org\/10.1016\/j.ejvs.2018.01.007.","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"763_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/0268355515596289","volume":"31","author":"N Langwieser","year":"2016","unstructured":"Langwieser N, Bernlochner I, Wustrow I, Dirschinger RJ, Jaitner J, Dommasch M, et al. Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstruction. Phlebology. 2016;31:430\u20137. https:\/\/doi.org\/10.1177\/0268355515596289.","journal-title":"Phlebology"},{"key":"763_CR13","unstructured":"Venous stenting after deep venous thrombosis and antithrombotic therapy: a systematic review - ClinicalKey. n.d. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S2212021114000150?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2212021114000150%3Fshowall%3Dtrue&referrer=. Accessed 15 May 2025."},{"key":"763_CR14","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00270-018-2062-5","volume":"41","author":"M Endo","year":"2018","unstructured":"Endo M, Jahangiri Y, Horikawa M, Kaufman JA, Schenning RC, Kolbeck KJ, et al. Antiplatelet therapy is associated with stent patency after iliocaval venous stenting. Cardiovasc Intervent Radiol. 2018;41:1691\u20138. https:\/\/doi.org\/10.1007\/s00270-018-2062-5.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"763_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/ATVBAHA.107.158691","volume":"28","author":"RD McBane","year":"2008","unstructured":"McBane RD, Leadley RJ, Baxi SM, Karnicki K, Wysokinski W. Iliac venous stenting, arterioscler. Thromb Vasc Biol. 2008;28:413\u20138. https:\/\/doi.org\/10.1161\/ATVBAHA.107.158691.","journal-title":"Thromb Vasc Biol"},{"key":"763_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1160\/TH09-04-0274","volume":"102","author":"AR Folsom","year":"2009","unstructured":"Folsom AR, Lutsey PL, Astor BC, Cushman M. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. Thromb Haemost. 2009;102:615\u20139. https:\/\/doi.org\/10.1160\/TH09-04-0274.","journal-title":"Thromb Haemost"},{"key":"763_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0741-5214(98)70060-6","volume":"28","author":"LJ Downing","year":"1998","unstructured":"Downing LJ, Strieter RM, Kadell AM, Wilke CA, Greenfield LJ, Wakefield TW. Low-dose low\u2013molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg. 1998;28:848\u201354. https:\/\/doi.org\/10.1016\/S0741-5214(98)70060-6.","journal-title":"J Vasc Surg"},{"key":"763_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/jth.15197","volume":"19","author":"P Notten","year":"2021","unstructured":"Notten P, ten Cate H, ten Cate-Hoek AJ. Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: a systematic review. J Thromb Haemost. 2021;19:753\u201396. https:\/\/doi.org\/10.1111\/jth.15197.","journal-title":"J Thromb Haemost"},{"key":"763_CR19","doi-asserted-by":"publisher","first-page":"e002772","DOI":"10.1161\/CIRCINTERVENTIONS.115.002772","volume":"8","author":"MK Razavi","year":"2015","unstructured":"Razavi MK, Jaff MR, Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis. Circ Cardiovasc Interv. 2015;8:e002772. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.115.002772.","journal-title":"Circ Cardiovasc Interv"},{"key":"763_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1055\/s-0042-1757340","volume":"39","author":"N Xiao","year":"2022","unstructured":"Xiao N, Genet M, Khaja M, Desai KR. Antithrombotic therapy after deep venous intervention. Semin Interv Radiol. 2022;39:357\u201363. https:\/\/doi.org\/10.1055\/s-0042-1757340.","journal-title":"Semin Interv Radiol"},{"key":"763_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jvsv.2021.10.014","volume":"10","author":"PJ Pappas","year":"2022","unstructured":"Pappas PJ, Lakhanpal G, Lakhanpal S, Sulakvelidze L, Tran M, Shetty A, et al. Immediate postprocedure anticoagulation with factor Xa inhibitors of venous stents for nonthrombotic venous lesions does not increase stent patency. J Vasc Surg Venous Lymphat Disord. 2022;10:633-639.e1. https:\/\/doi.org\/10.1016\/j.jvsv.2021.10.014.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"763_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1177\/0268355520941385","volume":"35","author":"MA Tran","year":"2020","unstructured":"Tran MA, Lakhanpal P, Lakhanpal S, Satwah VK, Lakhanpal G, Pappas PJ. Type of anti-thrombotic therapy for venous stenting in patients with non-thrombotic iliac vein lesions does not influence the development of in-stent restenosis. Phlebology. 2020;35:805\u201313. https:\/\/doi.org\/10.1177\/0268355520941385.","journal-title":"Phlebology"},{"key":"763_CR23","doi-asserted-by":"publisher","first-page":"109197","DOI":"10.1016\/j.thromres.2024.109197","volume":"244","author":"C Qiu","year":"2024","unstructured":"Qiu C, Huang L, Wang Y, Hu S, Zhong W, Lang D, et al. Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: a multicenter study with propensity score matching. Thromb Res. 2024;244:109197. https:\/\/doi.org\/10.1016\/j.thromres.2024.109197.","journal-title":"Thromb Res"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-026-00763-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:35Z","timestamp":1791576155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42155-026-00763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/s42155-026-00763-y","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with Institutional Review Board approval and complied with the Health Insurance Portability and Accountability Act. Patient informed consent was not required for this study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964\u202fHelsinki\u202fdeclaration\u202fand its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to the release and publication of the data included in this article.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"129"}}